ONCY
Oncolytics Biotech
ONCY
ONCY
28 hedge funds and large institutions have $1.86M invested in Oncolytics Biotech in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$231K |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$82K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$73.8K |
| 4 |
Jane Street
New York
|
+$69K |
| 5 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$51K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$299K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$50.8K |
| 3 |
Renaissance Technologies
New York
|
-$22K |
| 4 |
MFG
Magnus Financial Group
New York
|
-$14K |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$12.1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
Renaissance Technologies
New York
| – | -$22K | -37,751 | Closed |
|
|
MFG
27
Magnus Financial Group
New York
| – | -$14K | -25,000 | Closed |
|